TOIIW
The Oncology Institute IncNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-602.09
Beta
0.39
52W High
$0.27
52W Low
$0.03
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-7.97%
Forward P/E
—
PEG Ratio
—
About The Oncology Institute Inc
The Oncology Institute Inc. (TOIIW) stands as a leading provider of specialized cancer care, committed to offering high-quality, accessible treatment across a widespread network of outpatient facilities. With a focus on innovative therapies and a patient-centered model, the company seeks to improve clinical outcomes and elevate the patient experience amid a growing demand for specialized oncology services. Positioned for significant growth and market penetration, The Oncology Institute presents an attractive opportunity for institutional investors seeking to capitalize on the evolving landscape of cancer care.
Fundamentals
| Revenue (TTM) | $545.76M |
| Gross Profit (TTM) | $82.50M |
| EBITDA | $-25.91M |
| Operating Margin | -4.42% |
| Return on Equity | -4132.00% |
| Return on Assets | -12.30% |
| Revenue/Share (TTM) | $5.54 |
| Book Value | $-0.16 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 41.20% |
| Shares Outstanding | 0 |
| Float | $87.32M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
164.28%
HV 20-Day
221.51%
HV 30-Day
192.75%
HV 60-Day
—
HV Rank
—
Volatility is currently contracting
Data last updated: 7/9/2026